COST-EFFECTIVENESS (CE) OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX VERSUS PROTHROMBIN COMPLEX CONCENTRATE (PCC) IN THE TREATMENT OF HEMOPHILIA-B PATIENTS UNDERGOING KNEE SURGERY

Authors
Citation
B. Djulbegovic, COST-EFFECTIVENESS (CE) OF MONOCLONAL-ANTIBODY (MAB)-PURIFIED FACTOR-IX VERSUS PROTHROMBIN COMPLEX CONCENTRATE (PCC) IN THE TREATMENT OF HEMOPHILIA-B PATIENTS UNDERGOING KNEE SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 1036-1036
Citations number
NO
Categorie Soggetti
Hematology,"Cardiac & Cardiovascular System","Peripheal Vascular Diseas
Journal title
ISSN journal
03406245
Volume
73
Issue
6
Year of publication
1995
Pages
1036 - 1036
Database
ISI
SICI code
0340-6245(1995)73:6<1036:C(OM(F>2.0.ZU;2-0